These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39066710)

  • 1.
    Zhu J; Li M; Zhang Y; Lv Z; Zhao Z; Guo Y; Chen Y; Ren X; Cheng X; Shi H
    ACS Nano; 2024 Jul; ():. PubMed ID: 39066710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local Destruction of Tumors for Systemic Immunoresponse: Engineering Antigen-Capturing Nanoparticles as Stimulus-Responsive Immunoadjuvants.
    Lu J; Guo Z; Zheng R; Xie W; Gao X; Gao J; Zhang Y; Xu W; Ye J; Guo X; Tang J; Yu J; Wang L; Xu B; Zhang G; Zhao L
    ACS Appl Mater Interfaces; 2022 Feb; 14(4):4995-5008. PubMed ID: 35051331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-Capturing Dendritic-Cell-Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal-Therapy-Induced In Situ Vaccination.
    Li Y; Luo Y; Hou L; Huang Z; Wang Y; Zhou S
    Adv Healthc Mater; 2023 Sep; 12(22):e2202871. PubMed ID: 37276021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy-Triggered In Situ Tumor Vaccination Boosts Checkpoint Blockaded Immune Response via Antigen-Capturing Nanoadjuvants.
    Xu P; Ma J; Zhou Y; Gu Y; Cheng X; Wang Y; Wang Y; Gao M
    ACS Nano; 2024 Jan; 18(1):1022-1040. PubMed ID: 38131289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine-like nanomedicine for cancer immunotherapy.
    Yi Y; Yu M; Li W; Zhu D; Mei L; Ou M
    J Control Release; 2023 Mar; 355():760-778. PubMed ID: 36822241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid Metal Nanoplatform Based Autologous Cancer Vaccines.
    Wang D; Yu Z; Qi Y; Hu K; Zhou T; Liu J; Rao W
    ACS Nano; 2023 Jul; 17(14):13278-13295. PubMed ID: 37253081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reeducating Tumor-Associated Macrophages Using CpG@Au Nanocomposites to Modulate Immunosuppressive Microenvironment for Improved Radio-Immunotherapy.
    Cao Y; Ding S; Zeng L; Miao J; Wang K; Chen G; Li C; Zhou J; Bian XW; Tian G
    ACS Appl Mater Interfaces; 2021 Nov; 13(45):53504-53518. PubMed ID: 34704726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.
    Pierini S; Mishra A; Perales-Linares R; Uribe-Herranz M; Beghi S; Giglio A; Pustylnikov S; Costabile F; Rafail S; Amici A; Facciponte JG; Koumenis C; Facciabene A
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33563772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Situ Antigen-Capturing Nanochaperone Toward Personalized Nanovaccine for Cancer Immunotherapy.
    Li X; Zhang Y; Wu X; Chen J; Yang M; Ma F; Shi L
    Small; 2022 Aug; 18(32):e2203100. PubMed ID: 35843873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEI-Based Nanoparticles for Tumor Immunotherapy via In Situ Antigen-Capture Triggered by Photothermal Therapy.
    Chen W; Zhang M; Wang C; Zhang Q
    ACS Appl Mater Interfaces; 2023 Dec; 15(48):55433-55446. PubMed ID: 37976376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
    Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein sulfenic acid-mediated anchoring of gold nanoparticles for enhanced CT imaging and radiotherapy of tumors
    Ding J; Mao Q; Zhao M; Gao Y; Wang A; Ye S; Wang X; Xie W; Shi H
    Nanoscale; 2020 Nov; 12(45):22963-22969. PubMed ID: 33206090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy.
    Sun Z; Chu Y; Xiao J; Yang Y; Meng F; Wang X; Dong Y; Zhu J; Wu Y; Qin L; Ke Y; Liu B; Liu Q
    J Transl Med; 2023 Sep; 21(1):619. PubMed ID: 37700338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EISA in Tandem with ICD to Form In Situ Nanofiber Vaccine for Enhanced Tumor Radioimmunotherapy.
    Luo H; Cao H; Jia H; Shang Y; Liu J; Gui H; Yang C; Ren C; Wang Z; Liu J
    Adv Healthc Mater; 2023 Oct; 12(27):e2301083. PubMed ID: 37300544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree.
    Sheen MR; Fiering S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1524. PubMed ID: 29667346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy.
    Yang Q; Peng J; Shi K; Xiao Y; Liu Q; Han R; Wei X; Qian Z
    J Control Release; 2019 Aug; 308():29-43. PubMed ID: 31252039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer.
    He H; Liu L; Liang R; Zhou H; Pan H; Zhang S; Cai L
    Acta Biomater; 2020 Mar; 104():188-197. PubMed ID: 31945508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicines for an Enhanced Immunogenic Cell Death-Based
    Zhao C; Wang C; Shan W; Wang Z; Chen X; Deng H
    Acc Chem Res; 2024 Mar; 57(6):905-918. PubMed ID: 38417027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma.
    Pourhamzeh M; Asadian S; Mirzaei H; Minaei A; Shahriari E; Shpichka A; Es HA; Timashev P; Hassan M; Vosough M
    Mol Cell Biochem; 2023 Jan; 478(1):23-37. PubMed ID: 35708866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.